Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,656 across all filing types
Latest filing 2018-10-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
独立董事关于第二届董事会第三次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding matters discussed at the company's second board meeting, including the nomination of a non-independent director and a change in accounting policy. It references compliance with stock exchange listing rules and company bylaws. The content focuses on governance and board decisions rather than financial results or audit reports. The document length is short (943 characters), and it is not a full report but an opinion related to board matters. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or opinions related to the board of directors or senior management.
2018-10-26 Chinese
第二届董事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from Shenzhen BGI Genomics Co., Ltd. regarding the resolutions passed at the third meeting of the second board of directors. It includes details about the meeting's convening, attendance, and voting results on several agenda items such as approval of the 2018 third quarter report, election of a non-independent director, changes in accounting policies, and scheduling of the fourth extraordinary general meeting. The document also includes the biography of the newly nominated director. The content focuses on board meeting decisions and management changes rather than the full financial report itself. The document length is 2485 characters, which is relatively short and more consistent with a board/management announcement rather than a full quarterly report. Therefore, the appropriate classification is Board/Management Information (MANG).
2018-10-26 Chinese
关于召开2018年第四次临时股东大会的通知公告
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice about convening the 2018 fourth extraordinary general meeting of shareholders for Shenzhen BGI Genomics Co., Ltd. It includes information about the meeting date, time, location, agenda (such as the proposal to elect a non-independent director), voting procedures (including online voting), registration details, and attachments like proxy forms and voting instructions. There is no financial data or results reported, nor is it a transcript or presentation. It is clearly a formal announcement to shareholders about the upcoming shareholders' meeting and how to participate. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings.
2018-10-26 Chinese
关于补选公司第二届董事会非独立董事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of a non-independent director to the company's board following a resignation. It details the nomination, approval, and compliance with legal requirements for the board composition. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management changes, specifically the appointment of a new director. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not a report or a report announcement, so it is not an Annual Report or similar. Hence, the classification is MANG with high confidence.
2018-10-26 Chinese
关于实际控制人、部分董事、监事、高级管理人员、核心骨干人员及控股股东核心管理团队增持股份计划的进展公告
Director's Dealing Classification · 95% confidence The document is an announcement regarding the progress of a share increase plan by the company's actual controller, some directors, supervisors, senior management, core backbone personnel, and the controlling shareholder's core management team. It details the amounts, dates, and parties involved in the share purchases, including tables of shareholding changes and compliance with relevant securities laws. There is no financial statement or report content, but rather a disclosure of insider share purchases and progress updates on a previously announced share increase plan. This fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives (insider trades). The document length is under 5,000 characters, but it contains substantive information about share transactions, not just a brief announcement or a certification. Therefore, the appropriate classification is DIRS (Director's Dealing).
2018-10-17 Chinese
关于公司董事辞任的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company director, Mr. Wang Jun, from the board of Shenzhen BGI Genomics Co., Ltd. It details the resignation, the impact on the board, shareholding information, and confirms no disagreements with the board. There is no financial data, no report publication, no voting results, or other types of filings. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2018-10-16 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.